Expert Review of Pharmacoeconomics & Outcomes Research

Article	Citations
A landscape analysis and discussion of value of gene therapies for sickle cell disease	27
Content and cost of waste pharmaceuticals collected by pharmacies for disposal	20
How do patients value features of biological medicine in rheumatoid arthritis? A discrete choice experiment	20
Adherence to augmentation therapy for the treatment of major depressive disorder	20
A cost-effectiveness analysis of RefluxStop against relevant therapeutic alternatives for chronic gastroesophageal reflux disease in Sweden	15
Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening	14
Economic evaluation of interventions to improve medication adherence among patients with chronic diseases: an overview of systematic reviews	13
Analysis of prescriptive monitoring regarding the current therapeutic landscape of rheumatoid arthritis: the experience of an Italian local health authority	13
The cost-of-illness of multiple sclerosis in Jordan	13
Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care	13
The hidden burden of atopic dermatitis in central and Eastern European countries	13
The implications of cardiac device cybersecurity responsibilities and challenges faced by policymakers, manufacturers, and patients	12
Cost-effectiveness analysis of dupilumab versus omalizumab, mepolizumab, and benralizumab added to the standard of care in adults with severe asthma in Colombia	11
Economic evaluation of stereotactic radiotherapy and stereotactic radiosurgery technologies in the treatment of cancers: a systematic review	11
Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system	10
Hospital care of endometriosis in Spain: a retrospective multicenter analysis of patient characteristics and costs	10
Clinical and economic outcomes associated with intravenous albumin fluid use in the intensive care unit: a retrospective cohort study	10
How to create value with constrained budgets in oncological care? A narrative review	9
The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology	9
Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population	9
Direct medical and indirect absenteeism costs among working adult ADHD patients in the United States	8
Incorporating public and wider stakeholder views in the design of health state valuation studies in adults and young people: an undervalued resource?	8
Evaluating the correlations of cost and utility parameters from summary statistics for probabilistic analysis in economic evaluations	8
Cost-effectiveness analysis of first-line serplulimab plus chemotherapy for advanced squamous non-small-cell lung cancer in China: based on the ASTRUM-004 trial	8
A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer	8

How unprofessional behaviours between healthcare staff threaten patient care and safety	8
A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe	8
Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database	8
A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis	8
Indication-based pricing of the pharmaceuticals in Croatia: case-study	7
Analysis of patients’ access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece	7
Cost-effectiveness and drug wastage of immunotherapeutic agents for hematologic malignancies: a systematic review	7
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain	7
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?	7
Interview with Julie Frappier, health economist, and creator of the TOWWERS™ System	6
Economic benefits of global Collaborative Health technology	6
Using natural language processing to analyze unstructured patient-reported outcomes data derived from electronic health records for cancer populations: a systematic review	6
Nonadherence to antiseizure medications: what have we learned and what can be done next?	6
Assessing the economic impact of digital endpoints on medication adherence	6
Overview and quality assessment of health economic evaluations for homeopathic therapy: an updated systematic review	6
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer	6
Cost-effectiveness of somatrogon in the Spanish pediatric population with growth hormone deficiency	6
What to expect in 2024: important health economics and outcomes research (HEOR) trends	6
Effects of utilization management on health outcomes: evidence from urinary tract infections and community-acquired pneumonia	5
Economic evaluation of toripalimab plus chemotherapy compared with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma in China	5
Addressing racial/ethnic disparities associated with Medicare Part D Star Ratings among population with Alzheimer’s disease and related dementias	5
Tenecteplase in managing acute ischemic stroke: a long-term cost–utility analysis in Iran	5
Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review	5
Cost-effectiveness of hysterectomy, first- and second-generation endometrial ablation, and levonorgestrel-releasing device for treatment of heavy menstrual bleeding: a systematic review	5
Social care data in the UK; current landscape, challenges, and future recommendations	5
Cost-effectiveness of camrelizumab plus chemotherapy versus chemotherapy alone as first-line therapy in advanced or metastatic esophageal squamous cell carcinoma	5
Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications	5
Real-world analysis of cost, treatment patterns, and outcomes of patients with metastatic cutaneous squamous cell carcinoma in the US	5
Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study	5
Engagement of medication users in the development and implementation of digital medication adherence technologies: a multi-stakeholder study	5
Cost-effectiveness analysis of tofacitinib for the treatment of moderate to severe rheumatoid arthritis: a systematic review and meta-analysis	4
Psychometric properties of outcome measures for freezing of gait in Parkinson’s disease: a systematic review and meta-analysis	4
Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand	4
Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia	4
Clinical and economic impact analysis of viscosupplementation with hylan G-F 20 versus hyaluronic acids and no viscosupplementation for the treatment of knee osteoarthritis in Colombia	4
The clinical and economic burden of illness in the first two years after ostomy creation: a nationwide Danish cohort study	4
Cost-effectiveness of dapagliflozin plus standard treatment compared to standard therapy for the management of chronic kidney disease in Colombia	4
A retrospective observational analysis of the real-world care pathway of people with hereditary transthyretin amyloidosis with polyneuropathy in Italy	4
Risk prediction algorithms in guiding antiviral therapy initiation among patients with chronic hepatitis B in Thailand: an economic evaluation and budget impact analysis	4
Hospital incidence and costs of congenital hydrocephalus in Spain: a multicenter retrospective study	4
Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension	4
Prescription drug coverage satisfaction and medication nonadherence among Medicare beneficiaries with cancer	4
A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain	4
Value-based performance arrangements for chronic conditions: an economic simulation of Medicaid Drug Rebate Program reforms	4
Methodological standards for comparative effectiveness research: considerations for evidentiary review for medicare drug price negotiation	4
Economic evaluation of plerixafor addition in the mobilization and leukapheresis of hematopoietic stem cells for autologous transplantation: a systematic review	4
Cost-effectiveness analysis of atezolizumab plus chemotherapy as first-line treatment for patients with advanced nonsquamous non-small-cell lung cancer in China	4
The societal costs of multiple sclerosis in Lebanon: a cross-sectional study	4
Natural language processing – relevance to patient outcomes and real-world evidence	4
An early cost analysis of magnetic bone growth stimulation in England	4

The cost-effectiveness of using rapid diagnostic tests for the diagnosis of typhoid fever in patients with suspected typhoid fever: a systematic review	4
The cost-utility analysis of adding ocrelizumab to the treatment plan for primary progressive multiple sclerosis in Iran	4
Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A	4
Cost-effectiveness analysis of nivolumab-chemotherapy as first-line therapy for locally advanced/metastatic gastric cancer: a United States payer perspective	4
Disparities in Respiratory Syncytial Virus Risk Factors, Diagnosis, and Outcomes in Adults by Race, Ethnicity, and Other Social Determinants of Health in the United States	4
Work absenteeism, disability, and lost wages among patients with acute myeloid leukemia and their caregivers: a cohort study using US administrative claims and productivity data	4
Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment	4
The utility and impact of digital endpoints for improving breast cancer outcomes	4
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain	4
Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia	4
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis	4
Use of machine learning to predict bladder cancer survival outcomes: a systematic literature review	3
Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review	3
The budget impact of introducing the OMNI® surgical system to a United States health plan for managing mild-to-moderate primary open-angle glaucoma	3
Cost-effectiveness analysis: fluticasone furoate/umeclidinium/vilanterol for the treatment of moderate to severe chronic obstructive pulmonary disease from the perspective of the Chilean public health	3
Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis	3
Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer	3
Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control	3
Is Palbociclib a cost-effective strategy in the second-line treatment of metastatic breast cancer in Iran?	3
Direct diabetes-related healthcare expenditures in Slovenia: recent evolution and future projections based on population-level data	3
Value-based health care in Western countries: a scoping review on the implementation of patient-reported-outcomes sets for hospital-based interventions	3
Prescription analysis and cost of antidepressant drugs in major depressive disorder outpatients at the tertiary care hospital of Pakistan: a prospective approach	3
Seeing the whole elephant: integrated advanced data analytics in support of RWE for the development and use of innovative pharmaceuticals	3
The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach	3
Evaluation instruments for executive functions in children and adolescents: a systematic review	3
Tackling reimbursement challenges to fair access to medicines – introduction to the topic	3
Consumption of antidepressants and economic austerity in Brazil	3
Health-related quality of life measured using the EQ-5D-3L: iranian population norms	3
Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC)	3
Emerging trends: the involvement of community pharmacists in the planning and execution of pharmaceutical policies and economics	3
Economic evaluation of reproductive carrier screening for recessive genetic conditions: a systematic review	3
Measuring valued output in primary care: challenges and reconciliation	3
Cost of illness of stage IV non-small cell lung cancer (NSCLC) positive for programmed cell death ligand 1 (PD-L1) in the US	3
Budgetary impact analysis of alteplase - recombinant tissue plasminogen activator (rtPA) - as a thrombolytic treatment for acute ischemic stroke in Colombia	3
Methods for think-aloud interviews in health-related resource-use research: the PECUNIA RUM instrument	3
What might have happened: the impact of interrupting entry of innovative drugs on disease outcomes in the United States	3
A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury	3
Psychometric properties of the Polish version of SF-12v2 in the general population survey	3
Burden of illness the first year after diagnosed bladder dysfunction among people with spinal cord injury or multiple sclerosis – a Danish register study	3
Assessment of women’s treatment preferences for vasomotor symptoms due to menopause	3
Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?	3
Budget impact analysis of daratumumab for light-chain amyloidosis in Cyprus	3
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada	2
Value assessment of new interventions for Alzheimer’s disease dementia in Japan based on literature review and group interview	2
Assessment of the properties of the EQ-5D-5L in patients with type 2 diabetes mellitus: a systematic review and meta-analysis	2
Time from approval to reimbursement recommendations in healthcare systems with centralized HTA processes. Focus on the Polish HTA agency	2
Cost-effectiveness analysis of toripalimab plus chemotherapy for patients with advanced esophageal squamous cell carcinoma in China	2
Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Sing	2
Is the shift in treatment patterns towards new, more expensive drugs still driving the increase in pharmaceutical expenditure? A decomposition analysis of expenditure data in Sweden 1990–2022	2
Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review	2
Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil	2
Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore	2
Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review	2
Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension	2
Economic burden of depression in Brazil: a cost-of-illness study based on productivity losses and healthcare costs between 2010 to 2018	2
Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological ana	2
Burden of disease of spinal muscular atrophy linked to chromosome 5q (5q-SMA) in Colombia	2
Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines – a case study of oncology drugs	2
Evaluating reporting of patient-reported outcomes in peptic ulcer disease: a meta-epidemiological study of randomized controlled trials	2
Preferences of people with diabetes for diabetes care in Germany: a discrete choice experiment	2
Value attributes of advanced therapy medicinal products: a documentary analysis of comments received from stakeholders during reimbursement decisions to England’s National Institute of Health and Care	2
Economic evaluation of clinical pharmacy service using integrated health system in tertiary care hospital	2
The economic impact of pharmacist intervention during pandemics	2
A methodological guide for implementing and interpreting results of probabilistic analysis	2
How should we measure the use of social care and informal care?	2
Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer	2
The role of insurance policies in the drug pricing landscape	2
Evaluation of Antimicrobial Stewardship Programs and antibiotic prescribing patterns among physicians in ambulatory care settings in Jordan	2
COVID-19-related hospitalizations in Italy: an application of the synthetic control method to investigate the trajectory of diagnosis-related group 79 and its counterfactual during 2010–2021	2
Expert review of pharmacoeconomics and outcomes research: high impact articles from 2023	2
Cost comparison of F(ab’) 2 and Fab antivenoms for pit viper envenomation in the United States: a real-world analysis	2
Patient preferences in chronic immune-mediated inflammatory diseases potentially treated with biological drugs: discrete choice analysis using real-world data analysis	2
Canadian English translation and linguistic validation of the 13-MD to measure global health-related quality of life	2
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS II) statement: a validated Dutch translation	2
Cost-effectiveness of osimertinib in the treatment of advanced EGFR-mutated non-small cell lung cancer: a systematic review	2
The impact of under-investment on health in Southern and Central Eastern European Countries	2
Cost-effectiveness analysis of donafenib versus lenvatinib for first-line treatment of unresectable or metastatic hepatocellular carcinoma	2
Economic evaluation of ivabradine in treatment of patients with heart failure: a systematic review	2
Multiple sclerosis: economic burden, therapeutic advances, and future forecasts in the Middle East and North Africa region	2
Cost-effectiveness of blood-based colorectal cancer screening – a simulation model incorporating real-world longitudinal adherence	2

The Lebanese health economic evaluation guideline	2
Trastuzumab deruxtecan versus chemotherapy treated in patients with HER2-positive metastatic breast cancer: a cost-effectiveness analysis based on the DESTINY-Breast02 trial	2
Secondary healthcare resource utilization and related costs associated with influenza-related hospital admissions in adult patients, England 2016 – 2020	2
Effects, trends, costs associated with readmission in early-aged patients with suicidal ideation	2
Coping with increasing medicine costs through greater adoption of generic prescribing and dispensing in Pakistan as an exemplar country	2
Cost-utility analysis of multiple sclerosis rehabilitation in Iran	2
Enhancing pharmacist intervention targeting based on patient clustering with unsupervised machine learning	2
Predictors of 30-day readmission, mortality, and length of stay for hospitalized U.S. patients with Alzheimer’s and related dementias from 2010 to 2015	2
Burden of disease and costs of infections associated with cardiac implantable electronic devices	2
Assessing smoking cessation services and pharmacotherapy in Namibia: findings and implications for future policy initiatives	2
The long-term clinical impact of digital endpoints and biomarkers in data collection	2
Cost-effectiveness comparison of dalpiciclib and abemaciclib combined with an aromatase inhibitor as first-line treatment for HR+/HER2− advanced breast cancer	2
Cost of illness in multiple sclerosis by disease characteristics – A review of reviews	2
Cost-effectiveness analyses comparing cemented, cementless, hybrid and reverse hybrid fixation in total hip arthroplasty: a systematic overview and critical appraisal of the current evidence	2
Cost-utility analysis of duloxetine in osteoarthritis: from Chinese healthcare perspective	1
The challenge of value-based pricing in combination therapy: the case of trastuzumab and pertuzumab in HER2+ metastatic breast cancer	1
Regulatory perspectives on post-market evidence generation schemes for high-risk medical devices: a systematic review	1
Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal	1
Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder	1
Fiscal analysis of the pediatric immunization program in Belgium applying a lifetime government perspective framework	1
First-Line Tislelizumab for Advanced or Metastatic Esophageal Squamous Cell Carcinoma:A Cost-Effectiveness Analysis	1
Cost-effectiveness of anlotinib vs. pembrolizumab and nivolumab as third-line treatment in recurrent small cell lung cancer in China	1
Analysis of the prevalence of ankylosing spondylitis and treatment patterns and drug utilization among affected patients: an Italian real-world study	1
The economic value of knowing BRCA status: BRCA testing for optimizing treatment in recurrent epithelial ovarian cancer	1
A retrospective budget impact analysis of fidaxomicin treatment for Clostridioides difficile infections (CDI) in Germany	1
Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies — can alignment be improved?	1
Drug pricing and transparency in Europe and the United States: what is it and how does it work?	1
Pembrolizumab combined with chemotherapy versus placebo combined with chemotherapy for HER2-negative advanced gastric cancer in China: a cost-effectiveness analysis	1
Willingness to pay for cancer prevention versus treatment in China: implications for cost-effectiveness threshold	1
Leveraging the holistic benefits of biosimilars in Europe – part 2: how payers can safeguard the future of a healthy biosimilar market environment	1
Economic value of toripalimab plus axitinib as first-line treatment for advanced renal cell carcinoma in China: a model-based cost-effectiveness analysis	1
Direct healthcare costs for people with cerebral palsy in the Brazilian unified health system between 2015 and 2019	1
Digital measures in epilepsy in low-resourced environments	1
Mapping of the health of the Nation Outcomes Scale (HoNOS) and Positive and Negative Symptom Scale (PANSS) to the EQ-5D-3L in psychosis patients using the PHAMOUS study	1
An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55–64 and 65+ with aortic stenosis	1
Diabetes disparities in diabetes health care access and outcomes during the COVID-19 pandemic in the United States	1
Gene therapies, uncertainty, and decision-making: thinking about the last mile at the first step	1
Preference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experiment	1
The impact of comprehensive public hospital reform on economic burden of inpatients with chronic obstructive pulmonary disease: evidence from a pilot city in western China	1
Autologous stem-cell transplantation and maintenance therapy for transplant-eligible multiple myeloma patients: cost-effectiveness analysis based on a network meta-analysis	1
HTA challenges for appraising rare disease interventions viewed through the lens of an institutional multidimensional value framework	1
Matching-adjusted indirect comparison and cost-effectiveness of mitoxantrone hydrochloride liposome versus Chidamide in relapsed or refractory peripheral T-cell lymphoma in China	1
Cost-effectiveness of stereotactic body radiotherapy in the treatment of non–small-cell lung cancer (NSCLC): a systematic review	1
Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs	1
Work productivity in rheumatoid arthritis patients from two Latin American countries treated with tofacitinib or biological DMARDs	1
Burden of disease of chronic pain in Colombia	1
A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials	1
Policy solutions for medication non-adherence: what can governments do?	1
How can environmental impacts be incorporated in health technology assessment, and how impactful would this be?	1
Cost-consequence analysis of diagnosis and early treatment of acquired thrombotic thrombocytopenic purpura in Colombia	1
Cost effectiveness of hepatitis C direct acting agents	1
Review of economic modeling evidence from NICE appraisals of rare disease treatments for spinal muscular atrophy	1
Lorlatinib as a first-line treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: Α cost-effectiveness analysis in Greece	1
Payer and Developer perspectives on alternative payment models	1
Evaluation instruments for executive functions in children and adolescents: an update of a systematic review	1
Burden of osteoarthritis in the Netherlands: a scoping review	1
Monetary valuation of one year in full capability and health based on demographics, health status, income and well-being	1
Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health syst	1
Assessing the impact of kidney cancer-related premature mortality and productivity loss in Greece and Portugal	1
Imputing missing patient-level data and propensity score matching in cost-effectiveness analysis in Crohn's disease	1
The impact of bone turnover marker on medication adherence and the health economics-related consequences	1
Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia	1
Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective	1
Costs for global guideline-based diagnosis of mucormycosis in patients with neutropenia, hematopoietic stem cell, or solid organ transplantation – a perspective of the German healthcare system	1
Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events	1
Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries	1
Cost-utility analysis of sacituzumab govitecan versus chemotherapy for the treatment of metastatic triple-negative breast cancer in Singapore	1
Estimated value of productivity lost due to childhood chickenpox in the United Kingdom: a survey of parents	1
Cost-effectiveness of daratumumab in combination with lenalidomide and dexamethasone for relapsed and/or refractory multiple myeloma	1
Mapping the schizophrenia quality of life scale to EQ-5D, HUI3 and SF-6D utility scores in patients with schizophrenia	1
Understanding long-listed pharmaceutical products without competition in South Korea: policy implications in managing generic entrants and pharmaceutical expenditures	1
Design and testing of a health economic Markov model for treatment of anorexia nervosa	1
Using real world evidence to optimize care: the case of medical cannabis	1
Cost-effectiveness analysis of the first‐line EGFR‐TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer	1
Public value judgments about the criteria for reimbursement of medicines in South Korea	1
Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric/gastroesophageal junction cancer in the Chinese healthcare system	1
Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention	1
What are the costs of managing neck and low back pain in Brazil? Investigation of a ten-year period from the perspective of the Brazilian public health system	1
Capturing the holistic value of biosimilars in Europe – part 1: a historical perspective	1
Development of data processing algorithm to calculate adherence for adults with cystic fibrosis using inhaled therapy – a multi-center observational study within the CFHealthHub learning health system	1
A roadmap for applying machine learning when working with privacy-sensitive data: predicting non-response to treatment for eating disorders	1
Adherence to oral anticoagulants in patients with non-valvular atrial fibrillation: the role of patients’ characteristics and out-of-pocket payments	1
Perceptions of risk sharing agreements in South Korea from the viewpoints of key stakeholders: a convergent parallel mixed approach	1
The costs of treatment resistant depression: evidence from a survey among Italian patients	1
Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies	1
Budget impact analysis of medicines: estimated values versus real-world evidence and the implications	1
Technologies and decision-support tools for health systems management: a scoping review of features and use cases	1
Work productivity among patients with metastatic breast cancer in the United States	1
Cost-effectiveness of toripalimab plus chemotherapy versus chemotherapy as first-line treatment for advanced non-small cell lung cancer in China: a societal perspective	1
Value elements and methods of value-based pricing for drugs in Japan: a systematic review	1
Perspectives in prospective comparative economic evaluations: a systematic review	1
Cost-effectiveness analysis of atezolizumab plus bevacizumab and chemotherapy for the treatment of metastatic, persistent, or recurrent cervical cancer (BEATcc)	1
Cost-utility analysis of ceftazidime-avibactam versus colistin-meropenem in the treatment of infections due to Carbapenem-resistant Klebsiella pneumoniae in Colombia	1
Economic burden associated with stroke in India: insights from national sample survey 2017-18	1
The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States	1